Enter Karmen Lamer, founder of Toronto’s Tight Clinic, who has been on a relentless mission to bring the latest and most ...

Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

Researchers of the Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical Studies (HITS) have developed a synthetic peptide based on the natural protein ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

If you’re at all familiar with peptides, you’ll know the ingredient is banded about the beauty sphere as a miracle anti-ageing ingredient. It has been likened to Botox; it has been compared to ...

Disease-specific therapy, including enzyme replacement therapy (ERT ... is well described (online supplemental reference 4), and measurement of LV wall thickness, even when performed using CMR images, ...

The global biopharmaceutical drug delivery technologies market is projected to grow at a CAGR of 7.75%, reaching an expected revenue of USD 335.8 US, NY, UNITED STATES, January 30, 2025 /EINPresswire ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China ...